NuScale Power Shares Plunge Amid Growing Market Concerns

NuScale Power, once heralded as a promising contender in the nuclear energy sector, is facing a severe market reassessment. The company’s stock has experienced a dramatic decline following a dual wave of negative developments, raising questions about the viability of its small modular reactor technology.

Analyst Downgrade Sends Shockwaves

Citigroup has dramatically shifted its position on NuScale Power, downgrading the stock from “Neutral” to “Sell/High Risk” in a move that caught market participants by surprise. The investment bank simultaneously reduced its price target from $46 to $37.50, citing multiple fundamental concerns about the company’s prospects.

According to Citi’s analysis, NuScale faces several critical challenges including a lack of firm customer contracts, intensifying competition within the SMR marketplace, and what the bank considers an excessively optimistic valuation. The assessment presents a stark contrast to previous market enthusiasm surrounding the nuclear technology firm.

The analysis highlights what Citigroup views as unrealistic market expectations, noting that current valuations appear to price in approximately 16 gigawatts of reactor capacity by 2040. This projection significantly exceeds Citi’s forecast of just 56 gigawatts for the entire United States SMR market. Additionally, concerns were raised about the financial demands of NuScale’s planned massive partnership with TVA and ENTRA1 for over 6 gigawatts of capacity, which could strain the company’s $420 million in liquid assets.

Should investors sell immediately? Or is it worth buying Nuscale Power?

Shareholder Pressure Compounds Challenges

Simultaneously with the analyst downgrade, pressure is mounting from the shareholder side. Activist investment firm Starboard Value has taken action at Fluor Corp, which holds a substantial 40% stake in NuScale Power. Starboard is urging Fluor to reevaluate its position in NuScale, potentially creating additional selling pressure on the stock.

This negative sentiment overshadowed recent positive developments, including Cantor Fitzgerald’s initiation of coverage with an “Overweight” rating and a $55 price target. The optimistic outlook failed to counterbalance the prevailing downward trend.

Commercialization Hurdles Remain

NuScale confronts the fundamental challenge common to many advanced technology companies: transforming innovative technology into sustainable profitability. While the company holds the distinction of being the only SMR provider with certification from U.S. nuclear regulators, this achievement hasn’t yet translated into a robust business model without binding customer agreements.

The crucial test will come during the company’s upcoming quarterly presentation on November 6, where investors will be watching closely for evidence of progress in securing customers. Until then, market participants remain caught between concerns about further declines and hopes for NuScale’s role in the long-term nuclear energy transformation.